|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/13 | |
| A61K 31/445 | |||
| A61P 25/00 | |||
| A61K 9/16 | |||
| A61K 9/48 | |||
| A61K 9/70 |
| (11) | Number of the document | 2243475 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10075323.5 |
| Date of filing the European patent application | 2006-04-06 | |
| (97) | Date of publication of the European application | 2010-10-27 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 669290 P | 2005-04-06 | US | |
| 285905 | 2005-11-22 | US |
| (72) |
Went, Gregory T., US
Fultz, Timothy J., US
|
| (73) |
Adamas Pharmaceuticals, Inc.,
1900 Powell Street, Suite 750, Emeryville, CA 94608,
US
|
| (54) | Combination of memantine and donepezil for treatment of CNS disorders |
| Combination of memantine and donepezil for treatment of CNS disorders |